Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AMSF
AMSF logo

AMSF Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Amerisafe Inc (AMSF) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
32.330
1 Day change
2.96%
52 Week Range
47.860
Analysis Updated At
2026/06/18
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Amerisafe Inc (AMSF) is not a strong buy at the moment. While the stock shows stability and potential for modest long-term growth, the lack of significant positive catalysts, neutral trading sentiment, and absence of strong proprietary trading signals suggest that it is better to hold off on purchasing this stock for now. The investor's long-term strategy and beginner status align better with assets showing stronger growth signals or clearer positive momentum.

Technical Analysis

The MACD is slightly positive at 0.0484, indicating mild bullish momentum, but it is contracting. RSI is neutral at 51.581, showing no overbought or oversold conditions. Moving averages are converging, suggesting a lack of clear directional trend. Key support and resistance levels are close to the current price, with the pivot at 31.606, R1 at 32.219, and S1 at 30.993. Overall, the technical indicators suggest a neutral trend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
10

Positive Catalysts

  • The company experienced no large claims in Q1, and the CEO expressed confidence in sustaining top-line growth. Analysts expect lighter-than-typical catastrophe losses and modest negative impacts on book values.

Neutral/Negative Catalysts

  • Analysts have lowered price targets due to industry-wide pressures and valuation concerns in the P&C sector. There is no recent news or significant trading activity from hedge funds, insiders, or Congress. The stock has a 40% chance of declining slightly (-0.89%) in the next day and -0.72% in the next week.

Financial Performance

No financial data is available for the latest quarter, making it difficult to assess the company's recent growth trends.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed ratings. Truist lowered the price target to $34 from $36 with a Hold rating, citing valuation pressures. Citizens lowered the price target to $45 from $50 but maintained an Outperform rating, highlighting potential issues with casualty loss reserves and a challenging pricing environment.

Wall Street analysts forecast AMSF stock price to rise
1 Analyst Rating
Wall Street analysts forecast AMSF stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 31.400
sliders
Low
55
Averages
55
High
55
Current: 31.400
sliders
Low
55
Averages
55
High
55
Truist
Hold
downgrade
$36 -> $34
AI Analysis
2026-04-23
Reason
Truist
Price Target
$36 -> $34
AI Analysis
2026-04-23
downgrade
Hold
Reason
Truist lowered the firm's price target on Amerisafe to $34 from $36 and keeps a Hold rating on the shares after its Q1 earnings miss. The company experienced no large claims in the first quarter and the CEO expressed confidence that they should be able to sustain top-line growth, but the firm is lowering its price targets reflect pressure and valuations across the P&C industry, the analyst tells investors in a research note.
Citizens
Citizens
Outperform
downgrade
$50 -> $45
2026-04-13
Reason
Citizens
Citizens
Price Target
$50 -> $45
2026-04-13
downgrade
Outperform
Reason
Citizens lowered the firm's price target on Amerisafe to $45 from $50 and keeps an Outperform rating on the shares. The firm expects Q1 results to be highlighted by lighter-than-typical catastrophe losses, modest MTM negative impact on book values and ongoing potential for continued issues around casualty loss reserves. With that said, Citizens believes investor focus will be zeroed in on the pricing environment as weakness in certain areas, notably property, has spooked the market broadly and is now spreading to an increasing number of lines across the industry.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for AMSF
Unlock Now

People Also Watch